Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 67
Filter
Add more filters

Complementary Medicines
Publication year range
1.
Neurochem Res ; 45(7): 1576-1591, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32253649

ABSTRACT

This study investigated the effect of a high-fat diet rich in corn oil (CO-HFD) on the memory retention and hippocampal oxidative stress, inflammation, and apoptosis in rats, and examined if the underlying mechanisms involve modulating Resolvin D1 (RvD1) levels and activation of p66Shc. Also, we tested if co-administration of RvD1 could prevent these neural adverse effects induced by CO-HFD. Adult male Wistar rats were divided into 4 groups (n = 18/each) as control fed standard diet (STD) (3.82 kcal/g), STD + RvD1 (0.2 µg/Kg, i.p/twice/week), CO-HFD (5.4 kcal/g), and CO-HFD + RvD1. All treatments were conducted for 8 weeks. With normal fasting glucose levels, CO-HFD induced hyperlipidemia, hyperinsulinemia, increased HOMA-IRI and reduced the rats' memory retention. In parallel, CO-HFD increased levels of reactive oxygen species (ROS), malondialdehyde (MDA), cytoplasmic cytochrome-c, and cleaved caspase-3 and significantly decreased levels of glutathione (GSH), Bcl-2, and manganese superoxide dismutase (MnSOD) in rats' hippocampi. Besides, CO-HFD significantly reduced hippocampal levels of docosahexaenoic acid (DHA) and RvD1, as well as total protein levels of Nrf2 and significantly increased nuclear protein levels of p-NF-κB. Concomitantly, CO-HFD increased hippocampal protein levels of p-JNK, p53, p66Shc, p-p66Shc, and NADPH oxidase. However, without altering plasma and serum levels of glucose, insulin, and lipids, co-administration of RvD1 to CO-HFD completely reversed all these events. It also resulted in similar effects in the STD fed-rats. In conclusion, CO-HFD impairs memory function and induces hippocampal damage by reducing levels of RvD1 and activation of JNK/p53/p66Shc/NADPH oxidase, effects that are prevented by co-administration of RvD1.


Subject(s)
Corn Oil/adverse effects , Diet, High-Fat/adverse effects , Docosahexaenoic Acids/metabolism , Hippocampus/metabolism , Memory Disorders/metabolism , NF-E2-Related Factor 2/biosynthesis , Src Homology 2 Domain-Containing, Transforming Protein 1/metabolism , Animals , Docosahexaenoic Acids/pharmacology , Docosahexaenoic Acids/therapeutic use , Down-Regulation/drug effects , Down-Regulation/physiology , Hippocampus/drug effects , Male , Memory Disorders/prevention & control , Rats , Rats, Wistar , Retention, Psychology/drug effects , Retention, Psychology/physiology , Src Homology 2 Domain-Containing, Transforming Protein 1/antagonists & inhibitors , Up-Regulation/drug effects , Up-Regulation/physiology
2.
Eur J Pharmacol ; 862: 172632, 2019 Nov 05.
Article in English | MEDLINE | ID: mdl-31473161

ABSTRACT

Significant unmet needs exist for development of better pharmacotherapeutic agents for major depressive disorder (MDD) and post-traumatic stress disorder (PTSD) as the current drugs are inadequate. Our goal in this study is to investigate behavioral pharmacological characterization of a novel triple reuptake inhibitor (TRI) D-578 which exhibits nanomolar potency at all three monoamine transporters (Ki; 16.2. 16.2, 3.23 nM, and 29.6, 20.6, 6.10 nM for the rat brain and cloned human dopamine, serotonin and norepinephrine transporters, respectively) and exhibited little to no affinity for other off-target CNS receptors. In a rat forced swim test, compound D-578 upon oral administration displayed high efficacy and not stimulating in locomotor behavior. The effects of D-578 and paroxetine were next evaluated in a rat model for traumatic stress exposure - the single prolonged stress (SPS) model - which has been shown to have construct, predictive, and behavioral validity in modeling aspects of PTSD. Our results show that SPS had no effect on the acquisition of conditioned fear, but impaired extinction learning and extinction retention of fear behavior compared to sham treatment. D-578, but not paroxetine, attenuated the extinction and extinction-retention deficit induced by SPS. These findings suggest that D-578 has greater efficacy in normalizing traumatic stress-induced extinction-retention learning in a model for PTSD compared to paroxetine. Overall these results suggest that D-578, in addition to producing a robust and efficacious antidepressant effect, may attenuate maladaptive retention of fearful memories and support further testing of this agent for the pharmacotherapy of depression and PTSD.


Subject(s)
Antidepressive Agents/pharmacology , Depressive Disorder, Major/drug therapy , Neurotransmitter Uptake Inhibitors/pharmacology , Stress Disorders, Post-Traumatic/drug therapy , Stress, Psychological/complications , Administration, Oral , Animals , Antidepressive Agents/therapeutic use , Behavior Observation Techniques , Behavior, Animal/drug effects , Depressive Disorder, Major/etiology , Depressive Disorder, Major/psychology , Disease Models, Animal , Dopamine Plasma Membrane Transport Proteins/antagonists & inhibitors , Drug Evaluation, Preclinical , Humans , Male , Neurotransmitter Uptake Inhibitors/therapeutic use , Norepinephrine Plasma Membrane Transport Proteins/antagonists & inhibitors , Rats , Retention, Psychology/drug effects , Serotonin Plasma Membrane Transport Proteins/metabolism , Stress Disorders, Post-Traumatic/etiology , Stress Disorders, Post-Traumatic/psychology , Stress, Psychological/psychology
3.
Naunyn Schmiedebergs Arch Pharmacol ; 392(7): 813-821, 2019 07.
Article in English | MEDLINE | ID: mdl-30820610

ABSTRACT

Several lines of evidence suggest that sleep deprivation disrupts cognitive and emotional abilities and changes the expression of distinctive categories of genes in the brain. In the present study, saline- or MLC901 (a traditional Chinese medicine)-treated male Wistar rats were first submitted to a modified water box (for 24-h sleep deprivation) and then trained in contextual and tone fear conditioning tasks with the purpose to evaluate the effect of MLC901 during sleep deprivation on fear memory retention. Hippocampal mRNA measurement was performed by reverse transcription-polymerase chain reaction (RT-PCR). We found that the exposure of rats to 24 h of sleep deprivation impaired contextual and tone fear memory retention, while administration of MLC901 (0.2, 0.4, and 0.8 mg/kg, once/12 h; i.p.) during sleep deprivation abolished memory deficits. Meanwhile, different doses of MLC901 alone had no effect on performance in both tasks. We observed that MLC901 increased the expression levels of pro-apoptotic BAD, anti-apoptotic Bcl-xL, and Tfam as an index of mitochondrial biogenesis compared to sleep-deprived rats, while MLC901 during sleep deprivation increased BAX, BAD, and Bcl-xL compared to the control group. Sleep deprivation decreased BAX and Tfam, by itself. MLC901 only decreased BAX and Tfam and increased BAD level compared to the non-sleep-deprived control group. It is suggested that MLC901 might be a therapeutic option for memory impairment during sleep deprivation.


Subject(s)
Drugs, Chinese Herbal/pharmacology , Fear/drug effects , Hippocampus/drug effects , Memory Disorders/prevention & control , Sleep Deprivation/drug therapy , Animals , Apoptosis Regulatory Proteins/metabolism , Conditioning, Psychological , Disease Models, Animal , Dose-Response Relationship, Drug , Fear/psychology , Hippocampus/metabolism , Male , Memory Disorders/metabolism , Rats, Wistar , Retention, Psychology/drug effects , Sleep Deprivation/metabolism , Sleep Deprivation/psychology
4.
Neurosci Lett ; 622: 72-7, 2016 05 27.
Article in English | MEDLINE | ID: mdl-27113201

ABSTRACT

Learning and memory impairment occurs in diabetes. Salvia officinalis L. (SO) has been used in Iranian traditional medicine as a remedy against diabetes. We hypothesized that chronic administration of SO (400, 600 and 800mg/kg, p.o.) and its principal constituent, rosmarinic acid, would affect on passive avoidance learning (PAL) and memory in streptozocin-induced diabetic and non-diabetic rats. We also explored hypoglycemic and antioxidant activities of SO as the possible mechanisms. Treatments were begun at the onset of hyperglycemia. PAL was assessed 30days later. Retention test was done 24h after training. At the end, animals were weighed and blood samples were drawn for further analyzing of glucose and oxidant/antioxidant markers. Diabetes induced deficits in acquisition and retrieval processes. SO (600 and 800mg/kg) and rosmarinic acid reversed learning and memory deficits induced by diabetes and improved cognition of healthy rats. While the dose of 400mg/kg had no effect, the higher doses and rosmarinic acid inhibited hyperglycemia and lipid peroxidation as well as enhanced the activity of antioxidant enzymes superoxide dismutase and catalase. SO prevented diabetes-induced acquisition and memory deficits through inhibiting hyperglycemia, lipid peroxidation as well as enhancing antioxidant defense systems. Therefore, SO and its principal constituent rosmarinic acid represent a potential therapeutic option against diabetic memory impairment which deserves consideration and further examination.


Subject(s)
Antioxidants/pharmacology , Diabetes Mellitus, Experimental/drug therapy , Hypoglycemic Agents/pharmacology , Learning Disabilities/drug therapy , Memory Disorders/drug therapy , Plant Extracts/pharmacology , Salvia officinalis/chemistry , Animals , Antioxidants/therapeutic use , Avoidance Learning/drug effects , Cinnamates/pharmacology , Depsides/pharmacology , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/psychology , Hypoglycemic Agents/therapeutic use , Learning Disabilities/psychology , Male , Memory/drug effects , Memory Disorders/psychology , Oxidative Stress/drug effects , Plant Extracts/therapeutic use , Rats, Wistar , Retention, Psychology/drug effects , Rosmarinic Acid
5.
Physiol Behav ; 144: 37-45, 2015 May 15.
Article in English | MEDLINE | ID: mdl-25747767

ABSTRACT

Despite restrictions on their use, humans are still constantly exposed to organophosphates (OPs). A huge number of studies have ratified the neurotoxic effects of chlorpyrifos (CPF) and suggested its association with neurodegenerative diseases, but data are still scarce. Human apolipoprotein E (apoE) plays an important role in lipid transport and distribution. In humans, the apoE4 isoform has been linked to an increased risk of Alzheimer's disease (AD). ApoE3 is the most prevalent isoform worldwide, and has been often established as the healthful one. The current study, performed in targeted replacement (TR) adult male mice, aimed to inquire whether genetic variations of the human apoE respond differently to a chronic dietary challenge with CPF. At four/five months of age, mice carrying apoE2, apoE3 or apoE4 were pair-fed a diet supplemented with CPF at 0 or 2mg/kg body weight/day for 13weeks. Cholinergic signs were monitored daily and body weight changes weekly. In the last week of treatment, learning and memory were assessed in a Barnes maze task. Dietary CPF challenge increased body weight only in apoE3 mice. Differences in the acquisition and retention of the Barnes maze were attributed to apoE genetic differences. Our results showed that apoE4 mice performed worse than apoE2 and apoE3 carriers in the acquisition period of the spatial task, and that apoE2 mice had poorer retention than the other two genotypes. On the other hand, CPF increased the search velocity of apoE2 subjects during the acquisition period. Retention was impaired only in CPF-exposed apoE3 mice. These results underline that gene×environment interactions need to be taken into account in epidemiological studies. Given that apoE3, the most common polymorphism in humans, has proved to be the most sensitive to CPF, the potential implications for human health merit serious thought.


Subject(s)
Apolipoproteins E/genetics , Body Water/drug effects , Chlorpyrifos/toxicity , Cholinesterase Inhibitors/toxicity , Memory Disorders/chemically induced , Memory Disorders/genetics , Polymorphism, Single Nucleotide/genetics , Analysis of Variance , Animals , Cholinesterases/blood , Disease Models, Animal , Eating/drug effects , Genotype , Humans , Locomotion/drug effects , Locomotion/genetics , Male , Maze Learning/drug effects , Mice , Mice, Transgenic , Retention, Psychology/drug effects
6.
Behav Brain Res ; 252: 377-87, 2013 Sep 01.
Article in English | MEDLINE | ID: mdl-23810415

ABSTRACT

Pavlovian fear conditioning is an ideal model to investigate how learning and memory are influenced by alcohol use during adolescence because the neural mechanisms involved have been studied extensively. In Exp 1, adolescent and adult male Sprague-Dawley rats were non-injected or injected with saline, 1 or 1.5 g/kg ethanol intraperitoneally 10 min prior to tone or context conditioning. Twenty-four hours later, animals were tested for tone or context retention and extinction, with examination of extinction retention conducted 24h thereafter. In Exp 2, a context extinction session was inserted between the tone conditioning and the tone fear retention/extinction days to reduce pre-CS baseline freezing levels at test. Basal levels of acquisition, fear retention, extinction, and extinction retention after tone conditioning were similar between adolescent and adult rats. In contrast adolescents showed faster context extinction than adults, while again not differing from adults during context acquisition, retention or extinction retention. In terms of ethanol effects, adolescents were less sensitive to ethanol-induced context retention deficits than adults. No age differences emerged in terms of tone fear retention, with ethanol disrupting tone fear retention at both ages in Exp 1, but at neither age in Exp 2, a difference seemingly due to group differences in pre-CS freezing during tone testing in Exp 1, but not Exp 2. These results suggest that age differences in the acute effects of ethanol on cognitive function are task-specific, and provide further evidence for age differences cognitive functioning in a task thought to be hippocampally related.


Subject(s)
Aging/physiology , Central Nervous System Depressants/pharmacology , Conditioning, Classical/drug effects , Ethanol/pharmacology , Extinction, Psychological/drug effects , Fear/drug effects , Retention, Psychology/drug effects , Acoustic Stimulation/adverse effects , Analysis of Variance , Animals , Dose-Response Relationship, Drug , Male , Psychoacoustics , Rats , Rats, Sprague-Dawley , Time Factors
7.
Neurotoxicology ; 33(5): 1314-21, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22935099

ABSTRACT

Walnut is extensively used in traditional medicine for treatment of various ailments. It is described as an anticancer, anti-inflammatory, blood purifier and antioxidant agent. In this study, we investigated whether or not Walnut could protect neurons against cisplatin-induced neurotoxicity in rats. Dietary walnut (6%) was assessed for its neuroprotective effects through the alteration in performance of hippocampus- and cerebellum-related behaviors following chronic cisplatin treatment (5 mg/kg/week for 5 consecutive weeks) in male rats. We also evaluated the effect of cisplatin and walnut administration on nociception. We showed that exposure of adolescent rats to cisplatin resulted in significant decrease in explorative behaviors and memory retention. Walnut consumption improved memory and motor abilities in cisplatin treated rats, while walnut alone did not show any significant changes in these abilities compared to saline. Cisplatin increased latency of response to nociception, and walnut reversed this effect of cisplatin. We conclude that walnuts in the diet following anticancer drugs such as cisplatin might have a protective effect against cisplatin-induced disruptions in motor and cognitive function. However, further studies are needed to elucidate the exact mechanisms of this protective effect of walnut and to explore underlying mechanisms.


Subject(s)
Antineoplastic Agents/toxicity , Cisplatin/toxicity , Juglans , Neuroprotective Agents/therapeutic use , Neurotoxicity Syndromes/drug therapy , Neurotoxicity Syndromes/etiology , Animals , Animals, Newborn , Brain/pathology , Disease Models, Animal , Exploratory Behavior/drug effects , Hyperalgesia/drug therapy , Locomotion/drug effects , Male , Neural Conduction/drug effects , Neurons/drug effects , Neurons/metabolism , Nociception/drug effects , Peripheral Nerves/drug effects , Peripheral Nerves/physiopathology , Rats , Reaction Time/drug effects , Retention, Psychology/drug effects
8.
Pak J Biol Sci ; 15(22): 1085-9, 2012 Nov 15.
Article in English | MEDLINE | ID: mdl-24261125

ABSTRACT

There are several evidences that plants and vegetables with antioxidant activity can reduce oxidative damages in brain and improve cognitive functions. The aim of this study was evaluation of Nepeta menthoides aqueous extract on memory retention and retrieval of mice by using passive avoidance apparatus. For this purpose, mice were classified, coded, weighted and grouped (n = 8) as follow as: control group (Only electric shock), blank group (electric shock plus normal saline) and test groups (electric shock plus Nepeta menthoides extract by doses: 100, 200, 400 and 800 mg kg(-1), i.p.). Delay time of leaving the platform was measured for retention and retrieval test of memory in all mentioned groups. In retention test, plant extract was administered immediately after receiving electric shock while it was administered 24 h after receiving electric shock in retrieval. The results revealed that Nepeta menthoides aqueous extract significantly (p<0.05) increased memory retention and retrieval. The best response for memory retention and retrieval was achieved with 800 mg kg(-1) of Nepeta extract. In conclusion, enhancement of memory retention and retrieval by Nepeta menthoides could be cause of antioxidant activity of its components such as rosmarinic acid, caffeic acid and phenolic acids.


Subject(s)
Antioxidants/pharmacology , Behavior, Animal/drug effects , Mental Recall/drug effects , Nootropic Agents/pharmacology , Plant Extracts/pharmacology , Retention, Psychology/drug effects , Animals , Antioxidants/isolation & purification , Avoidance Learning/drug effects , Dose-Response Relationship, Drug , Electric Stimulation , Male , Mice , Nepeta/chemistry , Nootropic Agents/isolation & purification , Phytotherapy , Plant Extracts/isolation & purification , Plants, Medicinal , Reaction Time/drug effects , Time Factors
9.
J Med Food ; 14(9): 912-9, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21812651

ABSTRACT

Cognitive disorders such as dementia, attention deficits, and Alzheimer's disease (AD) have been well investigated. However, effective interventions for the promotion and progression of AD are unavailable to date. The present work was undertaken to investigate the effects of the aqueous (300 and 500 mg/kg) and alcoholic (300 and 500 mg/kg) extracts of Ocimum sanctum Linn. leaves as an antidementic and anticholinesterase agent and also as an immunostimulant in rats. Maximal electroshock, atropine, and cyclosporine were used to induce dementia. The passive avoidance task was used for assessing memory. Acetylcholinesterase (AChE) activity was estimated in different parts of the brain, and immune status was studied using dinitrochlorobenzene (DNCB) skin sensitivity tests. In all the three models both aqueous and alcoholic O. sanctum extracts decreased the time taken to reach the shock-free zone and the number of mistakes and significantly decreased the AChE activity in rats. O. sanctum treatment significantly increased the induration in the DNCB skin test. Therefore, O. sanctum was shown to be useful for the management of experimentally induced cognitive dysfunctions in rats.


Subject(s)
Cholinesterase Inhibitors/therapeutic use , Cognition/drug effects , Dementia/prevention & control , Nootropic Agents/therapeutic use , Ocimum/chemistry , Plant Extracts/therapeutic use , Acetylcholinesterase/metabolism , Adjuvants, Immunologic/administration & dosage , Adjuvants, Immunologic/pharmacology , Adjuvants, Immunologic/therapeutic use , Animals , Avoidance Learning/drug effects , Behavior, Animal/drug effects , Brain/drug effects , Brain/enzymology , Cholinesterase Inhibitors/administration & dosage , Cholinesterase Inhibitors/pharmacology , Dementia/chemically induced , Dementia/drug therapy , Dose-Response Relationship, Drug , GPI-Linked Proteins/antagonists & inhibitors , GPI-Linked Proteins/metabolism , Male , Medicine, Ayurvedic , Nerve Tissue Proteins/antagonists & inhibitors , Nerve Tissue Proteins/metabolism , Nootropic Agents/administration & dosage , Nootropic Agents/pharmacology , Plant Extracts/administration & dosage , Plant Extracts/pharmacology , Plant Leaves/chemistry , Rats , Rats, Wistar , Retention, Psychology/drug effects , Skin/drug effects , Skin/immunology
10.
Epilepsy Behav ; 21(4): 356-63, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21723789

ABSTRACT

The anticonvulsant effect of the hydroalcoholic extract of Zizyphus jujuba (HEZJ) fruit (100, 250, 500, and 1000 mg/kg, orally) was evaluated in experimental seizure models in rats. The effect of HEZJ on seizure-induced cognitive impairment, oxidative stress, and cholinesterase activity was also investigated. HEZJ (1000 mg/kg) exhibited maximum protection (100%) against generalized tonic-clonic seizures in the pentylenetetrazole (PTZ) seizure model and and 66.7% protection against tonic hindlimb extension in the maximal electroshock (MES) seizure model. Significant impairment in cognitive functions was observed in both PTZ- and MES-challenged rats. Pretreatment with HEZJ resulted in significant improvement in learning and memory. HEZJ also reversed the oxidative stress induced by both PTZ and MES. The significant decrease in cholinesterase activity observed in the PTZ and MES models was significantly reversed by pretreatment with HEZJ. Thus, the present study demonstrates the anticonvulsant effect of HEZJ as well as amelioration of cognitive impairment induced by seizures in rats.


Subject(s)
Cognition Disorders/drug therapy , Epilepsy/drug therapy , Oxidative Stress/drug effects , Phytotherapy , Plant Extracts/therapeutic use , Seizures/drug therapy , Ziziphus , Animals , Brain/drug effects , Brain/enzymology , Brain/physiopathology , Cholinesterases/metabolism , Cognition/drug effects , Cognition Disorders/enzymology , Cognition Disorders/physiopathology , Disease Models, Animal , Epilepsy/enzymology , Epilepsy/physiopathology , Male , Plant Extracts/pharmacology , Rats , Rats, Wistar , Retention, Psychology/drug effects , Seizures/enzymology , Seizures/physiopathology
11.
Hippocampus ; 21(6): 584-608, 2011 Jun.
Article in English | MEDLINE | ID: mdl-20232399

ABSTRACT

Status epilepticus (SE) in adulthood dramatically alters the hippocampus and produces spatial learning and memory deficits. Some factors, like environmental enrichment and exercise, may promote functional recovery from SE. Prenatal choline supplementation (SUP) also protects against spatial memory deficits observed shortly after SE in adulthood, and we have previously reported that SUP attenuates the neuropathological response to SE in the adult hippocampus just 16 days after SE. It is unknown whether SUP can ameliorate longer-term cognitive and neuropathological consequences of SE, whether repeatedly engaging the injured hippocampus in a cognitive task might facilitate recovery from SE, and whether our prophylactic prenatal dietary treatment would enable the injured hippocampus to more effectively benefit from cognitive rehabilitation. To address these issues, adult offspring from rat dams that received either a control (CON) or SUP diet on embryonic days 12-17 first received training on a place learning water maze task (WM) and were then administered saline or kainic acid (KA) to induce SE. Rats then either remained in their home cage, or received three additional WM sessions at 3, 6.5, and 10 weeks after SE to test spatial learning and memory retention. Eleven weeks after SE, the brains were analyzed for several hippocampal markers known to be altered by SE. SUP attenuated SE-induced spatial learning deficits and completely rescued spatial memory retention by 10 weeks post-SE. Repeated WM experience prevented SE-induced declines in glutamic acid decarboxylase (GAD) and dentate gyrus neurogenesis, and attenuated increased glial fibrilary acidic protein (GFAP) levels. Remarkably, SUP alone was similarly protective to an even greater extent, and SUP rats that were water maze trained after SE showed reduced hilar migration of newborn neurons. These findings suggest that prophylactic SUP is protective against the long-term cognitive and neuropathological effects of KA-induced SE, and that rehabilitative cognitive enrichment may be partially beneficial.


Subject(s)
Choline/administration & dosage , Hippocampus , Kainic Acid/adverse effects , Prenatal Nutritional Physiological Phenomena/physiology , Status Epilepticus , Animals , Female , Glial Fibrillary Acidic Protein/metabolism , Glutamate Decarboxylase/metabolism , Hippocampus/drug effects , Hippocampus/pathology , Humans , Male , Maze Learning/drug effects , Maze Learning/physiology , Memory Disorders/pathology , Neurogenesis/drug effects , Neurogenesis/physiology , Neurons/physiology , Pregnancy , Prenatal Exposure Delayed Effects , Rats , Rats, Sprague-Dawley , Retention, Psychology/drug effects , Space Perception/drug effects , Space Perception/physiology , Status Epilepticus/chemically induced , Status Epilepticus/diet therapy , Status Epilepticus/pathology , Status Epilepticus/prevention & control
12.
Neurobiol Learn Mem ; 95(3): 270-6, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21144907

ABSTRACT

Alzheimer's disease (AD) is a debilitating neurodegenerative disorder characterized by increased ß-amyloid (Aß) deposition and neuronal dysfunction leading to impaired learning and recall. Ageing, heredity, and induced oxidative stress are among proposed risk factors. The increased frequency of the disease in women also suggests a role for estrogen in development of AD. In the present study, effects of the phytoestrogen genistein (10mg/kg) on learning and memory impairments was assessed in intrahippocampal Aß(1-40)-injected rats. The estrogen receptor antagonist fulvestrant was injected intracerebroventricularly in a group of Aß-lesioned rats. The Aß-injected animals exhibited the following: lower spontaneous alternation score in Y-maze tasks, impaired retention and recall capability in the passive avoidance test, and fewer correct choices and more errors in the RAM task. Genistein, but not genistein and fulvestrant, significantly improved most of these parameters. Measurements of oxidative stress markers in hippocampal tissue of Aß-injected rats showed an elevation of malondialdehyde (MDA) and nitrite content, and a reduction of superoxide dismutase (SOD) activity. Genistein significantly attenuated the increased MDA content but did not affect the nitrite content or SOD activity. These results indicate that genistein pretreatment ameliorates Aß-induced impairment of short-term spatial memory in rats through an estrogenic pathway and by inducing attenuation of oxidative stress.


Subject(s)
Alzheimer Disease/prevention & control , Genistein/pharmacology , Hippocampus/drug effects , Maze Learning/drug effects , Memory, Short-Term/drug effects , Neuroprotective Agents/pharmacology , Alzheimer Disease/chemically induced , Amyloid beta-Peptides , Analysis of Variance , Animals , Avoidance Learning/drug effects , Disease Models, Animal , Estradiol/administration & dosage , Estradiol/analogs & derivatives , Estrogen Antagonists/administration & dosage , Fulvestrant , Hippocampus/metabolism , Hippocampus/physiopathology , Infusions, Intraventricular , Male , Malondialdehyde/metabolism , Memory, Short-Term/physiology , Mental Recall/drug effects , Microinjections , Oxidative Stress/drug effects , Peptide Fragments , Phytoestrogens/pharmacology , Random Allocation , Rats , Rats, Wistar , Retention, Psychology/drug effects , Statistics, Nonparametric , Thiobarbituric Acid Reactive Substances/metabolism
13.
J Ethnopharmacol ; 134(2): 203-9, 2011 Mar 24.
Article in English | MEDLINE | ID: mdl-21167268

ABSTRACT

AIM OF THE STUDY: Centella asiatica has a reputation to restore declining cognitive function in traditional medicine. To date, only a few compounds that show enhancing learning and memory properties are available. Therefore, the present study investigates the effects of for acute administration of asiatic acid (A-A) isolated from Centella asiatica administration on memory and learning in male Spraque-Dawley rats. MATERIALS AND METHODS: 4-5 weeks Spraque-Dawley rats were administered with concentration 1, 3, 5, 10, 30 mg/kg of A-A, baclofen, scopolamine and saline intra peritoneally and were evaluated for passive avoidance (PA), active avoidance (AA) and changes in blood pressure (BP). RESULTS: Treatment 30 mg/kg of A-A resulted in significantly dose-dependently improved memory, with increased retention latency to enter difference compartment in PA test compared to baclofen, saline and scopolamine. Furthermore, 30 mg/kg of A-A was significantly higher on learning abilities on 1st day but there was no significantly difference on avoidance memory ability after 7 days of retention. Low reading in blood pressure dose-dependent significantly difference was observed in the 30 mg/kg of A-A group compared to saline group. CONCLUSIONS: Administration A-A facilitated PA and AA on memory and learning and but had no effect on active avoidance on memory. Hence, may serve useful memory and learning with less effect in blood pressure in promoting memory and learning increases.


Subject(s)
Avoidance Learning/drug effects , Centella/chemistry , Central Nervous System Agents/pharmacology , Memory/drug effects , Neurotransmitter Agents/pharmacology , Pentacyclic Triterpenes/pharmacology , Plant Extracts/pharmacology , Animals , Baclofen/pharmacology , Blood Pressure/drug effects , Central Nervous System Agents/isolation & purification , Dose-Response Relationship, Drug , Male , Pentacyclic Triterpenes/isolation & purification , Rats , Rats, Sprague-Dawley , Retention, Psychology/drug effects , Scopolamine/pharmacology
14.
Learn Mem ; 17(9): 444-53, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20802017

ABSTRACT

A distributed limbic-corticostriatal circuitry is implicated in cue-induced drug craving and relapse. Exposure to drug-paired cues not only precipitates relapse, but also triggers the reactivation and reconsolidation of the cue-drug memory. However, the limbic cortical-striatal circuitry underlying drug memory reconsolidation is unclear. The aim of this study was to investigate the involvement of the nucleus accumbens core and the basolateral amygdala in the reconsolidation of a cocaine-conditioned stimulus-evoked memory. Antisense oligodeoxynucleotides (ASO) were infused into each structure to knock down the expression of the immediate-early gene zif268, which is known to be required for memory reconsolidation. Control infusions used missense oligodeoxynucleotides (MSO). The effects of zif268 knockdown were measured in two complementary paradigms widely used to assess the impact of drug-paired CSs upon drug seeking: the acquisition of a new instrumental response with conditioned reinforcement and conditioned place preference. The results show that both intranucleus accumbens core and intrabasolateral amygdala zif268 ASO infusions at memory reactivation impaired the reconsolidation of the memory underlying a cocaine-conditioned place preference. However, knockdown of zif268 in the nucleus accumbens at memory reactivation had no effect on the memory underlying the conditioned reinforcing properties of the cocaine-paired CS measured subsequently, and this is in contrast to the marked impairment observed previously following intrabasolateral amygdala zif268 ASO infusions. These results suggest that both the basolateral amygdala and nucleus accumbens core are key structures within limbic cortical-striatal circuitry where reconsolidation of a cue-drug memory occurs. However reconsolidation of memory representations formed during Pavlovian conditioning are differentially localized in each site.


Subject(s)
Amygdala/metabolism , Conditioning, Classical/physiology , Drug-Seeking Behavior/physiology , Early Growth Response Protein 1/metabolism , Nucleus Accumbens/metabolism , Retention, Psychology/physiology , Amygdala/drug effects , Animals , Central Nervous System Stimulants/pharmacology , Cocaine/pharmacology , Conditioning, Classical/drug effects , Cues , Drug-Seeking Behavior/drug effects , Gene Knockdown Techniques , Mental Recall/drug effects , Mental Recall/physiology , Microinjections , Neural Pathways/metabolism , Nucleus Accumbens/drug effects , Oligodeoxyribonucleotides, Antisense/administration & dosage , Rats , Rats, Inbred Strains , Retention, Psychology/drug effects
15.
Physiol Behav ; 100(2): 95-100, 2010 May 11.
Article in English | MEDLINE | ID: mdl-20159028

ABSTRACT

The role of zinc in the nervous system is receiving increased attention. At a time when dietary fortification and supplementation have increased the amount of zinc being consumed, little work has been done on the effects of enhanced zinc on behavior. Both zinc and copper are essential trace minerals that are acquired from the diet; under normal conditions the body protects against zinc overload, but at excessive dosages, copper deficiency has been seen. In order to examine the effect of enhanced metal administration on learning and memory, Sprague Dawley rats were given water supplemented with 10ppm Zn, 10ppm Zn+0.25ppm Cu, or normal lab water, during pre- and post-natal development. Fear conditioning tests at 4months showed significantly higher freezing rates during contextual retention and extinction and cued extinction for rats drinking water supplemented with zinc, suggesting increased anxiety compared to controls raised on lab water. During the MWM task at 9months, zinc-enhanced rats had significantly longer latencies to reach the platform compared to controls. The addition of copper to the zinc supplemented water brought freezing and latency levels closer to that of controls. These data demonstrate the importance of maintaining appropriate intake of both metals simultaneously, and show that long-term supplementation with zinc may cause alterations in memory.


Subject(s)
Carbonates/adverse effects , Carbonates/pharmacology , Carbonates/therapeutic use , Copper/pharmacology , Copper/therapeutic use , Fear/drug effects , Memory Disorders/drug therapy , Prenatal Exposure Delayed Effects/physiopathology , Space Perception/drug effects , Zinc Compounds/adverse effects , Analysis of Variance , Animals , Behavior, Animal , Cues , Extinction, Psychological/drug effects , Female , Freezing Reaction, Cataleptic/drug effects , Male , Maze Learning/drug effects , Memory Disorders/etiology , Photic Stimulation/methods , Pregnancy , Prenatal Exposure Delayed Effects/chemically induced , Rats , Rats, Sprague-Dawley , Retention, Psychology/drug effects
16.
J Gen Psychol ; 135(3): 271-86, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18649493

ABSTRACT

Young (2-4 months) and aged (14-16 months) male Swiss-Webster albino mice (n = 7 per group) were subcutaneously injected with 20 mg/kg/day dehydroepiandrosterone sulfate (DHEAS), progesterone (P), DHEAS + P, or vehicle control and trained over a 5-day period in a Morris water maze. The subjects were tested 48 hr after training for memory recall as measured by latencies to locate the hidden platform, and trunk blood was collected immediately thereafter. As expected, latency to platform decreased for all groups over the 6 testing days, with aged mice taking longer to reach platform than did young mice. However, results did not support the hypotheses that DHEAS-treated mice would exhibit shorter latencies and that P-treated mice would show longer latencies to platform in comparison with age-matched controls. These results raise doubts about the effectiveness of commercially available supplements claiming to promote enhanced memory in humans.


Subject(s)
Aging/drug effects , Dehydroepiandrosterone Sulfate/pharmacology , Escape Reaction/drug effects , Maze Learning/drug effects , Mental Recall/drug effects , Orientation/drug effects , Progesterone/pharmacology , Animals , Drug Interactions , Male , Mice , Reaction Time/drug effects , Retention, Psychology/drug effects
17.
Neurosci Lett ; 436(1): 19-22, 2008 May 02.
Article in English | MEDLINE | ID: mdl-18375059

ABSTRACT

Aging of the brain is characterized by several neurochemical modifications involving structural proteins, neurotransmitters, neuropeptides and related receptors. Alterations of neurochemical indices of synaptic function have been considered as indicators of age-related impairment of central functions, such as locomotion, memory and sensory performances. Several studies demonstrated that GABA receptors, glutamic acid decarboxylase (GAD65&67), and different subpopulations of GABAergic neurons are markedly decreased in experimental animal brains during aging. Thus, the age-related decline in cognitive functions could be attributable, at least in part, to decrements in GABA inhibitory neurotransmission. In this study, using a passive avoidance test, we show that chronic supplementation of taurine to aged mice significantly ameliorates the age-dependent decline in memory acquisition and retention. We have previously shown that taurine supplementation caused changes in the GABAergic system. These changes include increased levels of the neurotransmitters GABA and glutamate, increased expression of glutamic acid decarboxylase and the neuropeptide somatostatin and increase in the number of somatostatin-positive neurons. These specific alterations of the inhibitory system caused by taurine treatment oppose those naturally occurring in aging, and suggest a protective role of taurine against the normal aging process. Increased understanding of age-related neurochemical changes in the GABAergic system will be important in elucidating the underpinnings of the functional changes of aging. Taurine might help forestall the age-related decline in cognitive functions through alterations of the GABAergic system.


Subject(s)
Aging/physiology , Dietary Supplements , Learning/drug effects , Retention, Psychology/drug effects , Taurine/administration & dosage , Administration, Oral , Animals , Mice , Receptors, GABA/drug effects , Receptors, GABA/metabolism , gamma-Aminobutyric Acid/drug effects , gamma-Aminobutyric Acid/metabolism
18.
Memory ; 16(4): 410-9, 2008 May.
Article in English | MEDLINE | ID: mdl-18432485

ABSTRACT

A psychotropic placebo can help people resist the misinformation effect, an effect thought to be caused by a shift to more stringent source monitoring. When this shift occurs has been unclear. To address this issue we gave some people - but not others - a phoney cognitive-enhancing drug we called R273. Shortly afterwards, everyone took part in a misinformation effect experiment. To gather evidence about source monitoring we surreptitiously recorded time to read the misleading postevent narrative, and response time at test. Our findings suggest that people shifted to more stringent source monitoring at test. Moreover, people with higher working memory capacity (WMC) performed better than people with lower WMC - but only when they were told they had received R273, a finding that fits with research showing that WMC can confer advantages in situations demanding effortful control, but not when automatic heuristics suffice.


Subject(s)
Cognition/drug effects , Memory, Short-Term/drug effects , Placebo Effect , Placebos/pharmacology , Communication , Humans , Retention, Psychology/drug effects , Statistics as Topic , Suggestion , Time Factors
19.
Neurosci Lett ; 432(3): 206-11, 2008 Feb 27.
Article in English | MEDLINE | ID: mdl-18191327

ABSTRACT

Herbal therapies are commonly used to enhance memory and learning. Ginkgo biloba has shown to be one of the most popular herbs that is used to treat amnesia and retard age related memory deficits. Although, there have been several reports on the memory enhancing effects of Ginkgo, involvement of glutamatergic system that plays pivotal role in learning and memory has not been precisely assessed so far. The current study intended to investigate the effect of Ginkgo intake on amnesia while NMDA (N-methyl D-aspartic acid) receptors blocked by the administration of MK-801. The study used passive avoidance (PA) task to investigate the effect of chronic administration of Ginkgo extract (40 and 90 mg/kg; oral) on the memory span in male Wistar rats, suffering from MK-801-induced forgetfulness (0.06 and 0.1 mg/kg; i.p.). The results indicate that Ginkgo was able to remove MK-801-induced forgetfulness, indicating that Ginkgo can affect memory retention but not effect on passive avoidance acquisition, using pathways other than glutamatergic system as well. The results might indicate that Ginkgo extract can be effective in removing forgetfulness caused by inhibiting NMDA receptors from performing their activities.


Subject(s)
Avoidance Learning/drug effects , Ginkgo biloba/chemistry , Plant Preparations/pharmacology , Receptors, N-Methyl-D-Aspartate/physiology , Retention, Psychology/drug effects , Analysis of Variance , Animals , Behavior, Animal/drug effects , Dizocilpine Maleate/pharmacology , Dose-Response Relationship, Drug , Drug Interactions , Excitatory Amino Acid Antagonists/pharmacology , Male , Rats , Rats, Wistar , Reaction Time/drug effects
20.
Exp Clin Psychopharmacol ; 15(6): 576-87, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18179311

ABSTRACT

The authors assessed effects of alcohol consumption on different types of working memory (WM) tasks in an attempt to characterize the nature of alcohol effects on cognition. The WM tasks varied in 2 properties of materials to be retained in a 2-stimulus comparison procedure. Conditions included (a) spatial arrays of colors, (b) temporal sequences of colors, (c) spatial arrays of spoken digits, and (d) temporal sequences of spoken digits. Alcohol consumption impaired memory for auditory and visual sequences but not memory for simultaneous arrays of auditory or visual stimuli. These results suggest that processes needed to encode and maintain stimulus sequences, such as rehearsal, are more sensitive to alcohol intoxication than other WM mechanisms needed to maintain multiple concurrent items, such as focusing attention on them. These findings help to resolve disparate findings from prior research on alcohol's effect on WM and on divided attention. The results suggest that moderate doses of alcohol impair WM by affecting certain mnemonic strategies and executive processes rather than by shrinking the basic holding capacity of WM.


Subject(s)
Ethanol/pharmacology , Mental Recall/drug effects , Retention, Psychology/drug effects , Acoustic Stimulation/methods , Adult , Analysis of Variance , Auditory Perception/drug effects , Central Nervous System Depressants/analysis , Central Nervous System Depressants/blood , Central Nervous System Depressants/pharmacology , Color , Color Perception/drug effects , Dose-Response Relationship, Drug , Ethanol/analysis , Ethanol/blood , Female , Humans , Male , Photic Stimulation/methods , Psychological Tests , Sex Factors , Surveys and Questionnaires , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL